Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype

Journal Article · · Journal of Biological Chemistry
 [1];  [1];  [2];  [2];  [3];  [3];  [4];  [1];  [5];  [6];  [1];  [1];  [1]
  1. Univ. of Texas Health Science Center, San Antonio, TX (United States)
  2. Medical College of Wisconsin, Milwaukee, WI (United States)
  3. Univ. Nova de Lisboa (Portugal)
  4. Univ. of Michigan, Ann Arbor, MI (United States)
  5. State Univ. of New York Upstate Medical Univ., Syracuse, NY (United States)
  6. Charles Univ. in Prague (Czech Republic); General Univ. Hospital (Czech Republic)
Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Overall, current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); Fundação para a Ciência e a Tecnologia (FCT)
OSTI ID:
1328798
Journal Information:
Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 39 Vol. 291; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (66)

Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome journal January 2004
POR R457H is a global founder mutation causing Antley–Bixler syndrome with autosomal recessive trait journal January 2006
NMRPipe: A multidimensional spectral processing system based on UNIX pipes journal November 1995
Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase journal March 1995
Solubilization and partial characterization of rat liver squalene epoxidase. journal February 1975
Immunochemical Evidence for an Association of Heme Oxygenase with the Microsomal Electron Transport System journal June 1972
Evidence for a new physiological role of hepatic NADPH:ferricytochrome (P-450) oxidoreductase. Direct electron input to the microsomal fatty acid chain elongation system. journal October 1981
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study journal June 2004
Analytical and production seeding techniques journal August 1990
Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity journal February 2005
Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley–Bixler syndrome variants of cytochrome P450 oxidoreductase journal July 2008
Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization journal September 2011
Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism journal October 2010
Suppression of human cytochrome P450 aromatase activity by monoclonal and recombinant antibody fragments and identification of a stable antigenic complex journal March 2004
X-ray structure of human aromatase reveals an androgen-specific active site journal February 2010
Restoration of mutant cytochrome P450 reductase activity by external flavin journal June 2010
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases journal May 2013
Stopped-Flow Kinetic Studies of Flavin Reduction in Human Cytochrome P450 Reductase and Its Component Domains journal February 2001
Minor Activities and Transition State Properties of the Human Steroid Hydroxylases Cytochromes P450c17 and P450c21, from Reactions Observed with Deuterium-Labeled Substrates journal August 2012
Epoxidation Activities of Human Cytochromes P450c17 and P450c21 journal November 2014
Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase journal May 2009
Structural basis for androgen specificity and oestrogen synthesis in human aromatase journal January 2009
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome journal February 2004
Conformational exchange in the potassium channel blocker ShK journal December 2019
Multi-functionality of a tryptophan residue conserved in substrate-binding groove of GH19 chitinases journal January 2021
Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency journal May 2015
Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations journal January 2008
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency journal August 2011
Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN- and FAD-containing enzymes journal August 1997
Association of Multiple Developmental Defects and Embryonic Lethality with Loss of Microsomal NADPH-Cytochrome P450 Oxidoreductase journal December 2001
Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C–H BOND CLEAVAGE journal April 2015
Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase journal February 2003
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene: IMPACT ON PLASMA CHOLESTEROL HOMEOSTASIS AND THE FUNCTION AND REGULATION OF MICROSOMAL CYTOCHROME P450 AND HEME OXYGENASE journal April 2003
Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase journal September 2006
Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450 journal January 2009
Local fluctuations vs. global unfolding of proteins investigated by limited proteolysis journal January 2005
Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered Steroidogenesis journal May 2005
Riboflavin therapy journal December 1999
Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens journal January 1998
Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines journal April 2005
Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor journal March 2001
Effects of Cytochrome P450 Inhibitors on the Biotransformation of Fluorogenic Substrates by Adult Male Rat Liver Microsomes and cDNA-Expressed Rat Cytochrome P450 Isoforms journal October 2009
High‐level expression of functional human cytochrome P450 1A2 in Escherichia coli journal January 1992
Coot model-building tools for molecular graphics journal November 2004
Molecular replacement with MOLREP journal December 2009
Overview of the CCP 4 suite and current developments journal March 2011
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination journal September 1998
Functional Expression and Comparative Characterization of Nine Murine Cytochromes P450 by Fluorescent Inhibition Screening journal April 2008
Measurement of Membrane-Bound Human Heme Oxygenase-1 Activity Using a Chemically Defined Assay System journal January 2009
Human Cytochrome P450 Oxidoreductase Deficiency Caused by the Y181D Mutation: Molecular Consequences and Rescue of Defect journal November 2009
Altered Human CYP3A4 Activity Caused by Antley-Bixler Syndrome-Related Variants of NADPH-Cytochrome P450 Oxidoreductase Measured in a Robust In Vitro System journal January 2012
NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology journal October 2012
Formation of Large Unilamellar Vesicles by Extrusion book January 2006
Formation of Large Unilamellar Vesicles by Extrusion book September 2006
Formation of Large Unilamellar Vesicles by Extrusion book January 2006
Human Cytochrome P450c17: Single Step Purification and Phosphorylation of Serine 258 by Protein Kinase A journal February 2010
Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 Patients journal January 2005
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency journal February 2012
Coupled Motions Direct Electrons along Human Microsomal P450 Chains journal December 2011
Conditional Deletion of Cytochrome P450 Reductase in Osteoprogenitor Cells Affects Long Bone and Skull Development in Mice Recapitulating Antley-Bixler Syndrome: Role of a Redox Enzyme in Development journal September 2013
Overview of the CCP4 suite and current developments. text January 2011
Probing protein structure by limited proteolysis. journal June 2004
Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations journal April 2012
Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort journal March 2015
Restoration of mutant cytochrome P450 reductase activity by external flavin text January 2010

Cited By (6)

Accurate Determination of Human CPR Conformational Equilibrium by smFRET Using Dual Orthogonal Noncanonical Amino Acid Labeling journal January 2019
Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase journal January 2018
Accurate Determination of Human CPR Conformational Equilibrium by smFRET using Dual Orthogonal Non-Canonical Amino Acid Labeling posted_content September 2018
Loss of multiple enzyme activities due to the human genetic variation P284T in NADPH cytochrome P450 oxidoreductase posted_content May 2019
The Hinge Segment of Human NADPH-Cytochrome P450 Reductase in Conformational Switching: The Critical Role of Ionic Strength journal October 2017
Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450 journal December 2018